Lifitegrast significantly reduced corneal fluorescein staining ( superior , P = 0.0392 ; total cornea , P = 0.0148 ) and conjunctival lissamine staining ( nasal , P = 0.0039 ; total conjunctiva , P = 0.0086 ) at day 84 versus placebo .